about
Enhanced baculovirus-mediated transduction of human cancer cells by tumor-homing peptidesDisplay technologies: application for the discovery of drug and gene delivery agents.An unusual cell penetrating peptide identified using a plasmid display-based functional selection platform.Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis.Needle-shaped polymeric particles induce transient disruption of cell membranes.Transcriptionally targeted gene therapy to detect and treat cancer.Assessing the transport of receptor-mediated drug-delivery devices across cellular monolayersOcular neovascularisation and excessive vascular permeability.Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms.Preferential accumulation within tumors and in vivo imaging by functionalized luminescent dendrimer lanthanide complexes.Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cellsTargeted nanoparticle-based drug delivery and diagnosis.Targeted polymeric therapeutic nanoparticles: design, development and clinical translationWhat should be considered on design of a colon-specific prodrug?Avidin-biotin technology in targeted therapy.Silk-based delivery systems of bioactive molecules.Nanomaterials: applications in cancer imaging and therapy.Stimuli-sensitive synthetic polypeptide-based materials for drug and gene delivery.Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies.Transtumoral targeting enabled by a novel neuropilin-binding peptide.Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer.Navigare necessere est. Improved navigation would help to solve two crucial problems in modern drug therapy: toxicity and precise delivery.RGDS peptide inhibits activation of lymphocytes and adhesion of activated lymphocytes to human umbilical vein endothelial cells in vitro.Sequential changes in vessel formation and micro-vascular function during bone repair.Autonomous self-navigating drug-delivery vehicles: from science fiction to reality.Polymer conjugates for focal and targeted delivery of drugsLigand-Assisted Vascular Targeting of Polymer Therapeutics
P2860
Q33246815-7F399444-9BF8-48A6-BB75-C49CC0C93467Q33264491-D4FDEDA2-1D26-409C-8018-745574728408Q33811185-C7BFD732-46B8-4091-A772-011B037D017EQ33942372-C048202F-2D28-4C90-B732-0F48FE34F3F7Q34147654-0D24870E-64DB-4B16-9C6F-B62EBD329B0CQ35558678-C6DEABD2-FC63-41BC-9782-E5B2795C9CEEQ35636332-E02F76AC-A31C-40FD-8672-8B18024D72B7Q35873752-900E2FD0-320E-440C-AF9D-0CE0266B013EQ36015755-E0475012-4E65-4D8D-91A1-206DF9C4117BQ36449401-6D22D3AE-22FF-406A-BD4C-F1A572CBCF67Q36540861-413A246C-9CFE-4AE1-86FD-9E6A9D8A2C91Q36799773-0D18D468-F394-49FE-A91E-72D06A0C161BQ36934007-8C1149DF-97AD-4809-9186-F47B8DFA56F8Q37679957-180FDB31-1183-4543-AEBD-CE5F3A44C8DCQ37710089-ED7D1C1D-7C2B-42BF-AFEE-DED3DEB1E38DQ37714025-CAC1B26E-8EEB-4275-A92A-36486FCA5DFDQ37857064-5DF0D3DC-040A-44DD-B71A-0EF9DDFF5240Q38062891-D58C29DE-A795-49CD-93F3-52801E9A60F3Q38166550-27E1293B-9013-4CC6-B4E8-4A3F4D1950DAQ39426043-C1C26E11-0C28-4270-BCCA-D4FECEA3FBEDQ39497343-8DF42E0A-D443-4E3A-82E6-B7A8F66A7DB4Q42919601-DE5A2593-E816-495A-9C8F-10820EDB26B1Q45231420-30CF60E4-768D-4B3F-992F-F8AD16787DFDQ46281528-0A28E833-6774-405F-AF3B-A54C7CFF3C51Q47417419-A321C283-592C-46FE-BAF9-DED6682C26EFQ57617343-F029C03D-F4FC-4481-A7EB-3DE67E0CB092Q57617349-164372D3-BFC8-4666-A8AC-50DF3403ABE2
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Drug targeting to specific vascular sites.
@ast
Drug targeting to specific vascular sites.
@en
type
label
Drug targeting to specific vascular sites.
@ast
Drug targeting to specific vascular sites.
@en
prefLabel
Drug targeting to specific vascular sites.
@ast
Drug targeting to specific vascular sites.
@en
P1433
P1476
Drug targeting to specific vascular sites.
@en
P304
P356
10.1016/S1359-6446(02)02501-1
P577
2002-11-01T00:00:00Z